公告显示，公司审议通过了关于调整《境SHOW·生动莲花》项目内容并公开挂牌遴选合作方的议案。 拟在生动莲花项目现有基础上建设影剧院及相关配套设施，并在产权交易机构公开挂牌遴选合作方，由 合作方负责对该项目进行投资、建设和运营，银子岩公司向合作方收取固定租金及分成收入，相关合作 内容及具体金额以最终银子岩公司与遴选的合作方签署的协议为准。 11月19日晚间，桂林旅游（000978）公告称，公司投资建设的《境SHOW·生动莲花》项目总投资额1.1 亿元，项目地点位于桂林荔浦银子岩景区，由公司控股子公司桂林荔浦银子岩旅游有限责任公司（以下 简称"银子岩公司"）负责实施。截至目前，生动莲花项目涉及的建筑主体已基本建设完成，尚未正式营 业。截至2025年10月31日，公司累计投入资金1亿元。 不过，桂林旅游亦提示风险称，本次公开挂牌遴选合作方能否成功存在一定不确定性，存在未征集到符 合条件的合作方或最终合作未达成的风险。同时交易成功后，受经济环境、宏观政策、行业发展以及经 营管理等多方面不确定性因素的影响，该项目存在一定的开发、经营、管理和运作风险，从而导致未来 收益有可能不达预期。 桂林旅游主要从事旅游服务及与旅游服 ...

Core Points - The event "Leqi Pengcheng Quyou Jining" was held on October 28, marking the launch of the Jining cultural tourism promotion season in Shenzhen [1] - The event aimed to deepen cultural and tourism exchanges between Jining and the Guangdong-Hong Kong-Macao Greater Bay Area, promoting Jining's quality resources [1] - Key highlights included the introduction of the "Follow Confucius for Research Study" brand system and 18 premium research study routes, along with the announcement of exclusive welfare policies for tourists from the Pearl River Delta [1] - A cooperation agreement for mutual tourist exchange between Jining and the Pearl River Delta was signed, along with 12 cultural tourism projects [1]

Group 1 - Daqian Ecology announced that shareholder Xinhua Publishing Group plans to reduce its stake by up to 4,071,600 shares, representing no more than 3% of the total share capital [2] - Vice President Wang Zheng'an intends to reduce his holdings by up to 410,798 shares, which is no more than 25% of his total holdings and approximately 0.3027% of the company's total share capital [2] - The reduction period is set from June 16, 2025, to September 15, 2025 [2] Group 2 - Sanofi's stock has experienced a significant increase, with a cumulative rise of over 30% in two consecutive trading days and over 100% in four consecutive trading days, indicating abnormal trading fluctuations [2] - The company has entered into a collaboration with Pfizer for the 707 project, which involves a dual-specific antibody product targeting PD-1 and VEGF, with uncertain sales milestone payments and royalties based on market conditions [2] - The actual receipt of sales milestone payments and royalties is subject to uncertainties related to drug demand, market competition, and sales channels [2] Group 3 - Xinhua Insurance announced a commitment to invest 10 billion yuan in the second phase of the Honghu Fund, which has a total fund size of 20 billion yuan [3] - The establishment of the fund is pending regulatory procedures, and the implementation timeline may vary [3] - Sany Heavy Industry has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange, with the application materials being subject to updates [3] Group 4 - Laisentongling's stock has seen a 33.17% increase over three consecutive trading days, with a turnover rate of 40.49%, indicating potential speculative trading [3] - The company confirmed that its main operations remain stable, with no significant changes in daily operations or major contracts signed recently [3] - The production costs and sales conditions are reported to be normal [3]